Contribute Try STAT+ Today

It’s been two years since tech behemoth Amazon launched its joint venture in health care with Berkshire Hathaway and JPMorgan Chase. Called Haven, the initiative is aimed at cutting costs and improving quality with an immediate focus on serving the employees of the three companies. The secretive venture has so far generated lots of buzz but said little about how it will accomplish those goals.

Meanwhile, another experiment in revamping health care with tech tools has been a little more transparent. It was started nearly a decade ago on the campus of a different tech giant with bold health ambitions: Apple.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.